BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9290257)

  • 1. The growth hormone receptor gene mutation of a Japanese patient with Laron syndrome.
    Otsuka T; Iwatani N; Kodama M; Sakakida M; Shichiri M; Jinno Y; Niikawa N; Miike T
    Jpn J Hum Genet; 1997 Jun; 42(2):323-9. PubMed ID: 9290257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome.
    Berg MA; Guevara-Aguirre J; Rosenbloom AL; Rosenfeld RG; Francke U
    Hum Mutat; 1992; 1(1):24-32. PubMed ID: 1284474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome.
    Gastier JM; Berg MA; Vesterhus P; Reiter EO; Francke U
    Hum Mutat; 2000 Oct; 16(4):323-33. PubMed ID: 11013443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel growth hormone receptor gene deletion mutation in a patient with primary growth hormone insensitivity syndrome (Laron syndrome).
    Yamamoto H; Kouhara H; Iida K; Chihara K; Kasayama S
    Growth Horm IGF Res; 2008 Apr; 18(2):136-42. PubMed ID: 17728167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.
    Woods KA; Fraser NC; Postel-Vinay MC; Savage MO; Clark AJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1686-90. PubMed ID: 8626815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GH receptor gene mutations and growth failure].
    Kaji H
    Nihon Rinsho; 1998 Jul; 56(7):1830-5. PubMed ID: 9702061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I.
    Kang JH; Kim OS; Kim JH; Lee SK; Park YJ; Baik HW
    Int J Mol Med; 2012 Sep; 30(3):713-7. PubMed ID: 22751808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
    Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
    Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
    J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups.
    Shevah O; Rubinstein M; Laron Z
    Isr Med Assoc J; 2004 Oct; 6(10):630-3. PubMed ID: 15473594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme elevation of serum growth hormone-binding protein concentrations resulting from a novel heterozygous splice site mutation of the growth hormone receptor gene.
    Aalbers AM; Chin D; Pratt KL; Little BM; Frank SJ; Hwa V; Rosenfeld RG
    Horm Res; 2009; 71(5):276-84. PubMed ID: 19339792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
    Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
    Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
    Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel splice site mutation in the growth hormone receptor gene in Turkish patients with Laron-type dwarfism.
    Arman A; Ozon A; Isguven PS; Coker A; Peker I; Yordam N
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):47-58. PubMed ID: 18404972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
    Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
    Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intellectual capacity of patients with Laron syndrome (LS) differs with various molecular defects of the growth hormone receptor gene. Correlation with CNS abnormalities.
    Shevah O; Kornreich L; Galatzer A; Laron Z
    Horm Metab Res; 2005 Dec; 37(12):757-60. PubMed ID: 16372230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laron dwarfism and mutations of the growth hormone-receptor gene.
    Amselem S; Duquesnoy P; Attree O; Novelli G; Bousnina S; Postel-Vinay MC; Goossens M
    N Engl J Med; 1989 Oct; 321(15):989-95. PubMed ID: 2779634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically inactive growth hormone caused by an amino acid substitution.
    Takahashi Y; Shirono H; Arisaka O; Takahashi K; Yagi T; Koga J; Kaji H; Okimura Y; Abe H; Tanaka T; Chihara K
    J Clin Invest; 1997 Sep; 100(5):1159-65. PubMed ID: 9276733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.